Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2016

01-08-2016 | Erratum

Erratum to: A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A

Authors: Chiai Nagae, Atsuki Yamashita, Tomoko Ashikaga, Mika Mori, Mieko Akita, Kaoru Kitsukawa, Satoshi Yamazaki, Kimie Yoshikawa, Hitoshi Yamamoto, Masashi Taki

Published in: International Journal of Hematology | Issue 2/2016

Login to get access

Excerpt

The corresponding author of the article would like to add “Hitoshi Yamamoto” in the author group. The revised author group is as follows: …
Metadata
Title
Erratum to: A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A
Authors
Chiai Nagae
Atsuki Yamashita
Tomoko Ashikaga
Mika Mori
Mieko Akita
Kaoru Kitsukawa
Satoshi Yamazaki
Kimie Yoshikawa
Hitoshi Yamamoto
Masashi Taki
Publication date
01-08-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2055-6

Other articles of this Issue 2/2016

International Journal of Hematology 2/2016 Go to the issue

Progress in Hematology

Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia

Original Article

No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome

Original Article

A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A

Original Article

Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan

Original Article

Inhibition of human primary megakaryocyte differentiation by anagrelide: a gene expression profiling analysis

Images in Hematology

Myelomatous meningitis: a case report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits